Comparing the Explicit Tools vs. Implicit Evaluation Among Turkish Geriatric Outpatients

Bahat, Gülistan; İlhan, Bige Şimşek; Bay, Ilker; Avcı, Sinan; Tufan, Fatih; Kılıç, Cihan; Karan, Mehmet Akif

doi:10.1093/geroni/igx004.3830

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…People age 65 years and older, with at least one chronic disease are usually multiple medication users [9,10,17,18,31,32,33]. The proportion who take at least one PIM is between 22 and 56% [34,35].…”

Section: Discussionmentioning

confidence: 99%

“…The Beers Criteria constitute a consensus-based list of PIMs for individuals aged 65 years and older. They were first developed for nursing home residents in 1991 and have been updated twice, in 1997 and 2003, for use in the general elderly population based on new clinical evidence [10]. In 2015, the list of select drugs that should be avoided or subjected to dosage adjustments according to patient’s kidney function or select drug–drug interactions harmful to older adults was updated [11].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Association between Potentially Inappropriate Medication Use and Chronic Diseases in the Elderly

Wang

et al. 2019

IJERPH

View full text Add to dashboard Cite

Long-term continuous exposure to potentially inappropriate medications (PIMs) can lead to adverse events in the elderly. However, the effects of long-term exposure of the elderly to PIM and the relationship between PIM and chronic diseases remain unclear. The objective of this study was to investigate the continuous use of PIMs in a community-dwelling elderly population. A cross-sectional population-based study was conducted using community pharmacy–filed dispensing records from the Hcare system. Twenty-three community pharmacies were sampled from 2013 to 2015 to obtain records of patients above 65 years-old with continuous prescriptions. PIM were identified according to the 2015 Beers Criteria. The prevalence of patients using PIM was highest in patients with co-morbid mental disorders (40.05%), followed by neurological system disorders (28.91%). Patients who were prescribed a PIM were more than three times as likely to have a mental disorder as those (odds ratio 3.16, 95% confidence interval: 3.06–3.28) with non-chronic diseases. The most prescribed PIM agents were central nervous system drugs (53.16%), and benzodiazepines (35.15%). Patients with mental disorders had the highest rate of long-term persistent PIM exposure, with benzodiazepines being the most frequently dispensed. Drug safety concerns should be closely monitored in elderly patients with the abovementioned conditions.

show abstract